Patents & Commercial Assessment Workshop
|
|
- Dylan Barry Wilson
- 5 years ago
- Views:
Transcription
1 ANESTHESIOLOGY INNOVATION & ENTREPRENEURSHIP PROGRAM Patents & Commercial Assessment Workshop JUNE 6, 2015 SCHAUMBURG, IL Jointly provided by and
2 Patents & Commercial Assessment Workshop Activities in entrepreneurship and innovation are critical to the future of medicine, the health and safety of patients, and the continued advancement of anesthesiology. To facilitate physician education in these areas, the Foundation for Anesthesia Education and Research has created the Anesthesiology Innovation and Entrepreneurship Program, which underscores key elements of successful translational medical research and the scientific discoveries that advance patient care. This program houses novel activities that exemplify FAER s mission to advance medicine through research and education in anesthesiology. As part of the Anesthesiology Innovation and Entrepreneurship Program, FAER is hosting the Patents and Commercial Assessment Workshop. The workshop will expand knowledge of invention and innovation in anesthesia, activities that ultimately improve patient health. LEARNING OBJECTIVES At the conclusion of this activity, participants should be able to: Explain patents and why they are critical to product protection Compare different types of patents and patent processes Identify the patent application process Summarize how companies evaluate technology Identify effective ways to work with offices of technology licensing in an academic environment Recognize the importance of commercial assessment to the due diligence process TARGET AUDIENCE This activity is intended for anesthesiologists. Researchers and other health care professionals with an interest in anesthesiology may also participate. ACCME ACCREDITATION AND DESIGNATION STATEMENTS This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Society of Anesthesiologists and the Foundation for Anesthesia Education and Research. The American Society of Anesthesiologists is accredited by the ACCME to provide continuing medical education for physicians. The American Society of Anesthesiologists designates this live activity for 6.5 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity. INSTRUCTIONS ON HOW TO RECEIVE CREDIT In order to receive CME credit, participants must sign into the ASA Education Center, review the CME information and complete the evaluation. Further instructions will be ed to each participant immediately prior to and after the activity. DISCLAIMER The information provided at this CME activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient s medical condition. CONTACT INFORMATION Ginger Smith, Program Coordinator, Foundation for Anesthesia Education and Research, GingerSmith@faer.org,
3 Workshop Agenda The workshop will kick off with a series of sessions designed to educate attendees on all-things patents. After lunch, participants will take a deep dive into commercial assessment and technology licensing. Each attendee will have the opportunity to participate in four breakout sessions, two in the morning and two in the afternoon. Opportunities for Q-and-A will be provided at the conclusion of each session and during the specified roundtable sessions. TIME SESSION FACULTY LOCATION 7 a.m. Registration and Continental Breakfast Foyer/Atrium 7:45 a.m. Welcome and Opening Remarks Donn Dennis, MD, FAHA 8 a.m. Improving Patient Care through Innovation: Why We are Here Today 8:30 a.m. Patents, Patent Types and Their Role in Protecting Products 9 a.m. The Importance of Protecting Your Intellectual Property Ted Stanley, MD Pam Palmer, MD, PhD Linda E.B. Hansen, JD 9:30 a.m. Patents Roundtable and Q-and-A Linda E.B. Hansen, JD; Kirk Hogan, MD, JD; Pam Palmer, MD; Ted Stanley, MD (moderator) 10 a.m. Networking Break with Refreshments 10:30 a.m. Morning Breakout Sessions (two sessions, 45 minutes each) Noon - 1:30 p.m. Lunch and Keynote Presentation Fail Early, Fail Often but Don t Fail Always 1:30 p.m. How Do Companies Evaluate Technology? 2 p.m. Understanding the Technology Commercialization Process 2:30 p.m. Commercial Assessment Roundtable and Q-and-A 3 p.m. Networking Break with Refreshments 3:30 p.m. Afternoon Breakout Sessions (two sessions, 45 minutes each) See table below for session options See table below for session locations Steve Shafer, MD Multipurpose Room 3 Raul Trillo, MD, MBA Michael Villalobos, PhD William H. Burns; Donn Dennis, MD, FAHA; Raul Trillo, MD, MBA; Michael Villalobos, PhD See table below for session options See table below for session locations 5 p.m. Closing Reception Foyer, Outdoor Patio MORNING BREAKOUT SESSIONS SESSION FACULTY LOCATION Writing Effective Patents Pam Palmer, MD Multipurpose Room 1 Steps to Protecting Your Intellectual Property Linda E.B. Hansen, JD Multipurpose Room 2 Understanding Patent Law Kirk Hogan, MD, JD Conference Room A/B AFTERNOON BREAKOUT SESSIONS SESSION FACULTY LOCATION Legal Methods to Optimize Commercial Exclusivity Navigating the Corporate Business Development Process Working with Technology Licensing Office Teams in Academic Settings William (Bill) Burns Multipurpose Room 1 Raul Trillo, MD, MBA Multipurpose Room 2 Michael Villalobos, PhD 2 Conference Room A/B
4 Participating Faculty KEYNOTE PRESENTER STEVE SHAFER, MD Adjunct Professor, Stanford University PLANNING COMMITTEE MARK BICKET, MD Massachusetts General Hospital FEATURED PRESENTERS WILLIAM (BILL) BURNS Chief Executive Officer, NeuroproteXeon LINDA E.B. HANSEN, JD Partner, Intellectual Property Litigation, Foley & Lardner LLP KIRK HOGAN, MD, JD Professor, Anesthesiology, University of Wisconsin School of Medicine PAMELA (PAM) PALMER, MD, PHD Chief Medical Officer, Co-Founder, AcelRx Pharmaceuticals THEODORE (TED) STANLEY, MD Managing Director, Upstart Ventures RAUL TRILLO, MD, MBA Vice President of International Marketing Latin America, Baxter International Inc. MICHAEL (MIKE) VILLALOBOS, PHD Manager of Biotechnology Licensing, Vanderbilt Center for Technology Transfer and Commercialization DONN DENNIS, MD, FAHA University of Florida and Xhale, Inc. EVAN KHARASCH, MD, PHD Washington University in St. Louis TED STANLEY, MD University of Utah and Upstart Ventures DENHAM WARD, MD, PHD Foundation for Anesthesia Education and Research FAER STAFF SARA LUEDERS Marketing and Communications Manager GINGER SMITH Program Coordinator DAVID WOLFSON, CFRE Chief Development Officer NOTE: Please see page 9 of this syllabus for the complete list of planning committee, faculty and staff disclosures. 3
5 8-8:30 A.M., AUDITORIUM Improving Patient Care through Innovation: Why We Are Here Today TED STANLEY, MD MANAGING DIRECTOR, UPSTART VENTURES This session will define innovation and entrepreneurship, what they are and what they are not. It will provide examples of innovation and entrepreneurship within and outside of anesthesiology, and explain how the correct culture and other requirements are extremely important for innovation and entrepreneurship to be able to occur. In addition, this session will discuss why entrepreneurial activities are important to the future of anesthesiology and the future of our ability to provide improved patient care. Define innovation and entrepreneurship Discuss examples of past innovations and entrepreneurs in anesthesiology Identify the conditions that are necessary for innovation and entrepreneurship to occur Recognize why innovation and entrepreneurship are necessary for improved outcomes in anesthesiology and patient care 8:30-9 A.M., AUDITORIUM Patents, Patent Types and Their Role in Protecting Products PAMELA (PAM) PALMER, MD CHIEF MEDICAL OFFICER, CO-FOUNDER, ACELRX PHARMACEUTICALS This presentation will cover the different types of utility patents, key aspects of a patent, strategies behind provisional applications, public disclosure rules, patent examination process and updates to patent law, including Hatch-Waxman and the America Invents Act. Define the different types of utility patents Identify when filing a provisional application may be of benefit Discuss disclosure rules, recent changes and how they apply Explain the patent examination process 4
6 9-9:30 A.M., AUDITORIUM The Importance of Protecting Your Intellectual Property LINDA E.B. HANSEN, JD PARTNER, INTELLECTUAL PROPERTY LITIGATION, FOLEY & LARDNER LLP This session will cover the topics of ownership of inventions, patentability and licensing and why it is important to protect your intellectual property. 9:30-10 A.M., AUDITORIUM Patents Roundtable and Q-and-A Session MODERATOR: DONN DENNIS, MD, FAHA PANELISTS: LINDA E.B. HANSEN, JD; KIRK HOGAN, MD, JD; PAM PALMER, MD, PHD In an open Q-and-A session with the audience, led by the moderator, the panel will provide their perspectives on the key factors required to effectively write and file patents, and protect intellectual property. MORNING BREAKOUT SESSION, MULTIPURPOSE ROOM 1 Writing Effective Patents PAMELA (PAM) PALMER, MD CHIEF MEDICAL OFFICER, CO-FOUNDER, ACELRX PHARMACEUTICALS In this session, we will discuss patent strategies for start-up companies, including what to include in a provisional application and when to file one, how to create patentable data in early preclincial and pharmacokinetic studies, and how to work with the USPTO to get your patent approved. MORNING BREAKOUT SESSION, MULTIPURPOSE ROOM 2 Steps to Protecting Your Intellectual Property LINDA E.B. HANSEN, JD PARTNER, INTELLECTUAL PROPERTY LITIGATION, FOLEY & LARDNER LLP Intellectual property is the title given to various legal means of protecting ideas the creations of the mind. The growing importance of protecting intellectual property can be seen by the adoption of the Leahy-Smith America Invents Act on September 16, 2011, which brought the U.S. patent system into alignment with most of the rest of the world. Anyone with an idea worth patent protection should be careful to learn how to obtain the best protection for the greatest reward. Explain the different types of intellectual property protection available in the United States Define who owns an invention Identify how to protect an invention Describe what is patentable and what is not 5
7 MORNING BREAKOUT SESSION, CONFERENCE ROOM A/B Understanding Patent Law KIRK HOGAN, MD, JD PROFESSOR OF ANESTHESIOLOGY, UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE The America Invents Act that become effective March 16, 2013 comprises sweeping changes from earlier patent prosecution practice (i.e. steps necessary to get a patent). Patent applications filed before March 16, 2013 are subject to earlier statues and case law for up to 20 years, whereas those filed after March 16, 2013 are subject to provisions of the new law and corresponding court opinions. Accordingly, for the next 20 years, inventors must take parallel but distinct laws arising from the date of their application into account in seeking to maximize the value of their inventions. The workshop aims to address the new law s changes of greatest impact to the interests of the inventor and early-stage business, and identify best practices compatible with both. Distinguish between older first to invent system and the newer first to file or first to disclose system Identify best practices in the conduct and documentation of preclinical and clinical research and development in support of strong patent protection Identify the new law s changes that favor small inventors and businesses, and those that favor larger corporate entities LUNCHEON KEYNOTE PRESENTATION, MULTIPURPOSE ROOM 3 Fail Early, Fail Often but Don t Fail Always STEVE SHAFER, MD ADJUNCT PROFESSOR, STANFORD UNIVERSITY Dr. Shafer will share his personal stories of entrepreneurial misadventures. 1:30-2 P.M., AUDITORIUM How Do Companies Evaluate Technology? RAUL TRILLO, MD, MBA VICE PRESIDENT, INTERNATIONAL MARKETING, LATIN AMERICA, BAXTER You have an idea for a new product or technology. You ve invested some time, effort and resources to develop your concept further. You believe this could have great commercial value to the right company or commercial partner. How do you know if you re ready to showcase your idea? How do you think about who might be the right partner? What will the target company be looking for once you are ready? Identify the fundamentals and gain insights into what companies are looking for in a new product or technology Describe how companies perform commercial assessments Recognize what questions you should be asking yourself, and demonstrate how to better position your product or technology once you are ready to move forward Explain some of the ways companies view new technology opportunities and provide you with insights into the evaluation process 6
8 2-2:30 P.M., AUDITORIUM Understanding the Technology Commercialization Process MICHAEL (MIKE) VILLALOBOS, PHD MANAGER OF BIOTECHNOLOGY LICENSING, VANDERBILT CENTER FOR TECHNOLOGY TRANSFER AND COMMERCIALIZATION At times, the complexity and factors impacting the commercial potential of a technology can seem cryptic and daunting. This session will demystify the technology commercialization process and provide a step-wise approach to evaluating the commercial potential of a technology. List the key factors analyzed when evaluating a technology Discuss strategies for assessing the market and customers for a technology Demonstrate familiarity with the valuation and negotiation process 2:30-3 P.M., AUDITORIUM Commercial Assessment Roundtable and Q-and-A Session MODERATOR: TED STANLEY, MD PANELISTS: WILLIAM (BILL) BURNS; RAUL TRILLO, MD, MBA; MICHAEL (MIKE) VILLALOBOS, PHD In an open Q-and-A session with the audience, led by the moderator, the panel will provide their perspectives on the commercial assessment and technology valuation process. AFTERNOON BREAKOUT SESSION, MULTIPURPOSE ROOM 1 Legal Methods to Optimize Commercial Exclusivity WILLIAM (BILL) BURNS CHIEF EXECUTIVE OFFICER, NEUROPROTEXEON This session will focus on the three most prevalent methods of legally establishing commercial barriers to entry: 1) Patenting in the United States and International Markets; 2) Grants of regulatory exclusivity in the United States and international markets; 3) Contracting. Explain where intellectual property (principally patents) provide real product protection Recognize the extent certain drug and device approvals provide regulatory exclusivity and the role of orphan product status in extending the duration of exclusivity Discuss the role of hospital contracts in effectively extending exclusivity 7
9 AFTERNOON BREAKOUT SESSION, MULTIPURPOSE ROOM 2 Navigating the Corporate Business Development Process RAUL TRILLO, MD, MBA VICE PRESIDENT, INTERNATIONAL MARKETING, LATIN AMERICA, BAXTER A company representative expresses interest in your new product or technology. You ve already had a preliminary presentation, and you re told the company wants to conduct additional due diligence. Shortly, you will be receiving a request for more information. What should you expect? What information should you provide? Whose information needs are you trying to satisfy? List the key stakeholders and decision makers involved in the corporate business development process Describe the expectations and information needs of the key stakeholders in order to navigate the process more smoothly Discuss potential pitfalls one might face as your product or technology is evaluated AFTERNOON BREAKOUT SESSION, CONFERENCE ROOM A/B Working with Technology Licensing Office Teams in Academic Settings MICHAEL (MIKE) VILLALOBOS, PHD MANAGER OF BIOTECHNOLOGY LICENSING, VANDERBILT CENTER FOR TECHNOLOGY TRANSFER AND COMMERCIALIZATION Most academic/research institutions have a technology licensing office, but working with them can seem foreign to an inventor. This session will guide the audience through the value and expertise a technology licensing office and provide in the technology commercialization process. Additionally, attendees will gain an understanding of how to use the technology licensing office to maintain their relationship with a potential licensee during the license negotiation process. Explain how to work with your technology licensing office and gain value from the partnership Describe how to use the technology licensing office expertise in marketing a technology and leverage the TLO during negotiations Discuss the goals of the technology licensing office 8
10 Honoring A True Innovator, Dr. David Paulus David Paulus, M.D., had a passion for patient care, a strong commitment to his specialty, and he understood the importance of innovation in advancing medicine. Dr. Paulus, an anesthesiologist and professor of anesthesiology at the University of Florida, passed away unexpectedly in 2012 at the age of 67. He was also a professor of in the College of Engineering s department of mechanical engineering. Cook Medical is honoring Dr. Paulus legacy through the David Paulus Anesthesia Fund. In the spirit of the late Dr. Paulus, whose memory is being honored by the Anesthesiology Innovation and Entrepreneurship Program, this workshop will advance medicine and improve healthcare by providing anesthesiologists and trainees with the tools and knowledge needed to transform their discoveries and innovations into patient care. Commercial Support COMMERCIAL SUPPORT ACKNOWLEDGMENT This CME activity is supported by educational grants from AcelRx, Cook Medical, Masimo and Piramal. PLANNER, FACULTY AND STAFF DISCLOSURES Individual Role Commercial Interest Nature of Relationship William H. Burns Faculty NeuroproteXeon Self, Salary, Ownership, Equity Paxx Pharma Piramal Self, Ownership Self, Consulting Donn Dennis Faculty, Planning Committee Xhale, Inc. Self, Salary, Ownership, Equity Position, Stock Options University of Florida HyGreen, Inc. NanoMedex Self, Royalties Self, Ownership, Equity Position, Stock Options Self, Ownership, Equity Position Pamela Palmer Faculty AcelRx Self, Salary, Ownership, Equity Position, Stock Options Raul Trillo Faculty Baxter Healthcare Self, Equity Position, Stock Options Steve Shafer Faculty Signature Therapeutics Self, spouse/partner, Equity Position Johnson and Johnson The Medicines Company Hospira Self, Consulting Fees Self, Consulting Fees Evan Kharasch Planning Committee The Medicines Company Self, Honoraria Spouse/partner, Consulting Fees The following planning committee members, faculty and staff have reported that they have no financial relationships with commercial interests to disclose: Linda E.B. Hansen, Kirk Hogan, Theodore Stanley, Michael Villalobos, Mark Bicket, Denham Ward, Ginger Smith, Sara Lueders, David Wolfson, Linda Matherson. DISCLOSURE POLICY The American Society of Anesthesiologists remains strongly committed to providing the best available evidence-based clinical information to participants of this educational activity and requires an open disclosure of any potential conflict of interest identified by our faculty members. It is not the intent of the American Society of Anesthesiologists to eliminate all situations of potential conflict of interest, but rather to enable those who are working with the American Society of Anesthesiologists to recognize situations that may be subject to question by others. All disclosed conflicts of interest are reviewed by the educational activity course director/chair to ensure that such situations are properly evaluated and, if necessary, resolved. The American Society of Anesthesiologists educational standards pertaining to conflict of interest are intended to maintain the professional autonomy of the clinical experts inherent in promoting a balanced presentation of science. Through our review process, all American Society of Anesthesiologists CME activities are ensured of independent, objective, scientifically balanced presentations of information. Disclosure of any or no relationships will be made for all educational activities. 9
11 Learn More About FAER OUR MISSION To advance medicine through research and education in anesthesiology. ABOUT FAER The Foundation for Anesthesia Education and Research (FAER) is a 501(c)3 non-profit, and a related organization of the American Society of Anesthesiologists (ASA). Its mission is to advance medicine through anesthesiology research and education. FAER is committed to ensuring physician anesthesiologists lead medicine into the future through scientific discovery and the creation of new knowledge. SUPPORT THE FUTURE OF ANESTHESIOLOGY Advances in anesthesiology are made possible by individuals who believe in education and research. Supporting talented anesthesiologists through the formative stages of their careers will expand research in anesthesiology, and will benefit our specialty, our medical centers and, most importantly, our patients. You can support research and education in anesthesiology by making a gift to FAER. ONLINE Donations made online have an immediate effect on FAER s ability to provide ongoing support for our programs and grants. You can make an online donation to FAER using your credit card. Visit FAER.org/donate to make your contribution today. SUSTAINING GIFT Your monthly, quarterly or semi-annual recurring gift of any amount is an excellent way to provide sustained support for anesthesia education and research. You can set up a recurring gift to FAER by visiting FAER.org/donate. BY MAIL You can support the future of anesthesiology by mailing a check to FAER. Send it to us at: Foundation for Anesthesia Education and Research 1061 American Lane Schaumburg, IL BY PHONE You can call FAER s office at to make a credit card donation. Our business hours are Monday through Friday, 8 a.m. to 5 p.m. CT. When you call, you may inform us whether your gift is a tribute in honor or in memory of a mentor, colleague, friend or family member. OTHER WAYS TO GIVE There are a number of ways to support FAER philanthropically. If you are interested in making a planned gift or would like to personalize your contribution to FAER, contact us at
12 1061 American Lane Schaumburg, IL
Discovery: From Concept to the Patient - The Business of Medical Discovery. Todd Sherer, Ph.D.
Discovery: From Concept to the Patient - The Business of Medical Discovery Todd Sherer, Ph.D. Associate Vice President for Research and Director of OTT President Elect, Association of University Technology
More informationTECHNOLOGY TRANSFER AT THE UNIVERSITY OF TENNESSEE: INVENTIONS AND COMMERCIALIZATION
utrf@tennessee.com TECHNOLOGY TRANSFER AT THE UNIVERSITY OF TENNESSEE: INVENTIONS AND COMMERCIALIZATION Hot Topics in Research, May 23, 2017 Richard Magid, PhD UTRF Vice President WHAT IS TECHNOLOGY TRANSFER?
More informationUntying the Gordian Knot:
Untying the Gordian Knot: Providing Order in the Invention Disclosure Process Workshop Topics 1. Inventor Relations 2. Technology Scouting 3. Crafting Disclosures Processes 4. Disclosure Evaluation and
More informationLatin American Venture Capital & Private Equity Academy
Page 0 2015 Latin American Venture Capital & Private Equity Academy DRAFT SCHEDULE ANN LEAMON AND JOSH LERNER Page 1 The Latin American Venture Capital & Private Equity Academy This two-day session is
More informationCollaborating with the Office of Technology Transfer
Collaborating with the Office of Technology Transfer Todd Sherer, Ph.D. Associate Vice President for Research and Executive Director Office of Technology Transfer Emory Owns Our IP As a condition of employment,
More informationAbout the National Academy of Inventors
About the National Academy of Inventors Founded at USF in 2010 A 501(c)(3) non-profit member organization U.S. and international universities, and governmental and non-profit research institutes 3,000
More informationLoyola University Maryland Provisional Policies and Procedures for Intellectual Property, Copyrights, and Patents
Loyola University Maryland Provisional Policies and Procedures for Intellectual Property, Copyrights, and Patents Approved by Loyola Conference on May 2, 2006 Introduction In the course of fulfilling the
More informationUW REGULATION Patents and Copyrights
UW REGULATION 3-641 Patents and Copyrights I. GENERAL INFORMATION The Vice President for Research and Economic Development is the University of Wyoming officer responsible for articulating policy and procedures
More informationTechnology Transfer: Working with Industry at MIT. 10 February 2009 Kenneth A. Goldman Manager, Corporate Relations MIT Industrial Liaison Program
Technology Transfer: Working with Industry at MIT 10 February 2009 Kenneth A. Goldman Manager, Corporate Relations MIT Industrial Liaison Program Observations Innovation is key to economic growth; impact
More informationINTELLECTUAL PROPERTY POLICY
INTELLECTUAL PROPERTY POLICY Overview The University of Texas System (UT System) Board of Regents (Board) and the University of Texas Health Science Center at San Antonio (Health Science Center) encourage
More informationTRANSLATIONAL SCIENCE
TRANSLATIONAL SCIENCE A Discussion of Best Practices and Unique Models Wednesday January 31, 2018 at The NYSCF Research Institute HRA TRI-STATE REGIONAL MEETING 31 Wednesday January, 2018 AGENDA 8:30 AM
More informationAIMed Artificial Intelligence in Medicine
Medical Intelligence and Innovation Institute (MI3) Presents The First International Multidisciplinary Symposium on Artificial Intelligence in Medicine: Analytics and Algorithms, Big Data, Cloud and Cognitive
More informationChallenging Times: Sustaining Your Business While Waiting for Financing. January 14, 2009
Challenging Times: Sustaining Your Business While Waiting for Financing January 14, 2009 Attorney Advertising Prior results do not guarantee a similar outcome Models used are not clients but may be representative
More informationCelebrating International Women's Day Friday, March 8, :30am-1:00pm
Co-Hosted by: Join us in Launching the 1st Annual Successful Women of San Diego Executive Leadership Panel Celebrating International Women's Day Friday, March 8, 2019 11:30am-1:00pm Sponsored by: Location:
More informationGetting the Most From Your IP Budget: Strategies for IP Portfolio Management and Litigation Avoidance
Getting the Most From Your IP Budget: Strategies for IP Portfolio Management and Litigation Avoidance March 19, 2009 A Web conference hosted by Foley & Lardner LLP Welcome Moderator Andrew Rawlins, Partner,
More informationAGENDA. Whole Health Innovation Collaborative Meeting: Applying Precision to Preventative Health and Personalized Medicine
AGENDA Whole Health Innovation Collaborative Meeting: Applying Precision to Preventative Health and Personalized Medicine April 25, 2017 AGENDA 8:00 am Registration and Continental Breakfast (Guildhall
More informationGuidelines for Facilitating the Use of Research Tool Patents in the Life Sciences. March 1, 2007 Council for Science and Technology Policy
Guidelines for Facilitating the Use of Research Tool Patents in the Life Sciences March 1, 2007 Council for Science and Technology Policy 1. Introduction (1) In the domains of medicine and biotechnology,
More informationTranslation University of Tokyo Intellectual Property Policy
Translation University of Tokyo Intellectual Property Policy February 17, 2004 Revised September 30, 2004 1. Objectives The University of Tokyo has acknowledged the roles entrusted to it by the people
More informationPANEL DISCUSSION & ROUNDTABLES
LIFE SCIENCES & HEALTH CARE EVENT Road to commercialization - Challenges, Opportunities & Successes that lie ahead in the Life Sciences and Healthcare Sectors Life Sciences and Healthcare is one of the
More informationIntellectual Property
Intellectual Property Johnson & Johnson believes that the protection of intellectual property (IP) is essential to rewarding innovation and promoting medical advances. We are committed: to raising awareness
More informationThe Cannabis Industry Growth Opportunities for Professionals, Operators and Investors
The Cannabis Industry Growth Opportunities for Professionals, Operators and Investors Conference Program Tuesday October 17, 2017 Hilton Boston Dedham TABLE OF CONTENTS SECTION PAGE OUR PARTNERS Thank
More informationPergamon Corporation CONFRENCE
Pergamon Corporation CONFRENCE IP Stategy, Patent Portfolio Development and InnovationEarn CLE Dissecting the evolving spectrum of intellectual property rights, and licensing to foster innovation May 23-24,
More informationClinical Safety & Effectiveness Cohort # 11
Clinical Safety & Effectiveness Cohort # 11 Compliance in the Documentation of Verbal Disclosure of Relevant Financial Relationships with Commercial Interests from Presenters DATE Educating for Quality
More informationSeptember 18, 2017 Special Called Meeting of the U. T. System Board of Regents - Meeting of the Board
AGENDA SPECIAL CALLED TELEPHONE MEETING of THE UNIVERSITY OF TEXAS SYSTEM BOARD OF REGENTS September 18, 2017 Austin, Texas Page CONVENE THE BOARD IN OPEN SESSION TO RECESS TO EXECUTIVE SESSION PURSUANT
More informationTriton Technology Fund
Triton Technology Fund Presentation to Dean s Engineering Council March 22, 2013 Generate Returns for LPs/GPs Motivation for Fund Catalyze translation of UCSD discoveries for the benefit of society Enable
More informationAmerican Health Lawyers Association Health Care Transactions May 1-3, 2019 Nashville, TN
American Health Lawyers Association May 1-3, 2019 Nashville, TN Wednesday, May 1, 2019 A. Fundamental: Overview of the Deal Process A Roadmap through the Paper Jungle Schaff Sharnoff Stroup D. Fundamental:
More informationLISA TILTON-McCARTHY
LISA TILTON-McCARTHY Lisa Tilton-McCarthy received a B.A. in English from Texas A&M University in College Station and graduated summa cum laude from South Texas College of Law in Houston. She was Editor-in-Chief
More informationIntellectual Property
Intellectual Property Technology Transfer and Intellectual Property Principles in the Conduct of Biomedical Research Frank Grassler, J.D. VP For Technology Development Office for Technology Development
More informationTHE CENTER FOR WOMEN S ENTREPRENEURIAL LEADERSHIP AT BABSON
THE CENTER FOR WOMEN S ENTREPRENEURIAL LEADERSHIP AT BABSON PREPARING WOMEN TO LEAD THE WORLD. PREPARING THE WORLD FOR WOMEN LEADERS. BABSON COLLEGE S CENTER FOR WOMEN S ENTREPRENEURIAL LEADERSHIP (CWEL)
More informationMerriann M. Panarella, Esq. Panarella Dispute Resolution Services P.O. Box Wellesley, MA
Merriann M. Panarella, Esq. Panarella Dispute Resolution Services P.O. Box 812179 Wellesley, MA 02482 mpanarella@panarellaadr.com 508 653-2455 Dispute Resolution Services Dispute resolution services include
More informationIntellectual Property & Technology Transfer
Intellectual Property & Technology Transfer Welcome to the Sub-group on IP and Tech Transfer We are delighted you have joined us! Fred Reinhart University of Massachusetts Robert Hardy Council on Governmental
More informationLewis-Clark State College No Date 2/87 Rev. Policy and Procedures Manual Page 1 of 7
Policy and Procedures Manual Page 1 of 7 1.0 Policy Statement 1.1 As a state supported public institution, Lewis-Clark State College's primary mission is teaching, research, and public service. The College
More informationIP and Technology Management for Universities
IP and Technology Management for Universities Yumiko Hamano Senior Program Officer WIPO University Initiative Innovation and Technology Transfer Section, Patent Division, WIPO Outline! University and IP!
More informationCONFE R E NC E AG E NDA
CONFE R E NC E AG E NDA A DVA MED PAYMENT POL ICY As the reimbursement and coverage landscapes for the medical technology industry are continuously changing, s 4th Annual Payment Policy Conference will
More informationPolicy on Patents (CA)
RESEARCH Effective Date: Date Revised: N/A Supersedes: N/A Related Policies: Policy on Copyright (CA) Responsible Office/Department: Center for Research Innovation (CRI) Keywords: Patent, Intellectual
More informationGoverning Council. Inventions Policy. October 30, 2013
University of Toronto Governing Council Inventions Policy October 30, 2013 To request an official copy of this policy, contact: The Office of the Governing Council Room 106, Simcoe Hall 27 King s College
More informationJagadguru Sri Shivarathreeshwara University (Deemed University) Accredited A Grade by NAAC ONE DAY SEMINAR
Jagadguru Sri Shivarathreeshwara University (Deemed University) Accredited A Grade by NAAC ONE DAY SEMINAR ON Challenges to Patentability in Pharma Sector Date: 16 th September 2017 10:00 AM to 4:30 PM
More informationManaging IP Assets Throughout the. Patent Lifecycle
Managing IP Assets Throughout the Patent Lifecycle You or your clients have invested heavily in developing and acquiring intellectual property. In some cases you may have been threatened by others with
More informationParenteral Nutrition Down Under Inc. (PNDU) Working with Pharmaceutical Companies Policy (Policy)
Parenteral Nutrition Down Under Inc. (PNDU) Working with Pharmaceutical Companies Policy (Policy) BACKGROUND (Reason or Purpose) The purpose of this Policy is to provide clear principles and guidance about
More informationTechnology Transfer and the University: an orientation for new faculty at Johns Hopkins University
Johns Hopkins Technology Transfer Bringing the benefits of discovery to the World. Technology Transfer and the University: an orientation for new faculty at Johns Hopkins University Wesley D. Blakeslee,
More informationIntellectual Property Ownership and Disposition Policy
Intellectual Property Ownership and Disposition Policy PURPOSE: To provide a policy governing the ownership of intellectual property and associated University employee responsibilities. I. INTRODUCTION
More informationPerspectives of Innovative Small Companies on the Industry s Prospects for 2012 and Beyond
Perspectives of Innovative Small Companies on the Industry s Prospects for 2012 and Beyond ACI Forum on Structuring, Negotiating and Managing Life Sciences Collaborations and Acquisitions February 28,
More informationEL PASO COMMUNITY COLLEGE PROCEDURE
For information, contact Institutional Effectiveness: (915) 831-6740 EL PASO COMMUNITY COLLEGE PROCEDURE 2.03.06.10 Intellectual Property APPROVED: March 10, 1988 REVISED: May 3, 2013 Year of last review:
More informationOur Mission Assistance Case Studies Press Room IPAO Forum HOME : IPAO Forum search Search the Forum Please sign in: Email ******** Forgot Password sign in Register > Commentaries on IP issues by experts
More informationPatent Law: What Anesthesiologists Should Know
Patent Law: What Anesthesiologists Should Know Kirk Hogan MD, JD ISAP 23 rd Annual Meeting October 10, 2014 khogan@wisc.edu, kjhogan@casimirjones.com How Nobody Invented Anesthesia (J. M. Fenster, American
More informationFinal Pitch Competition PROGRAM GUIDE. Wednesday, March 2, 2016 at HIMSS16 VENETIAN - PALAZZO - SANDS EXPO CENTER LEVEL 3 - LIDO 3104 LAS VEGAS, NV
Final Pitch Competition PROGRAM GUIDE Wednesday, March 2, 2016 at HIMSS16 VENETIAN - PALAZZO - SANDS EXPO CENTER LEVEL 3 - LIDO 3104 LAS VEGAS, NV #HITVenture #HIMSS16 1 Presented by: WEDNESDAY, MARCH
More informationFinancing Growth Ventures to Minimize Equity Dilution
Financing Growth Ventures to Minimize Equity Dilution An entrepreneurial team s mission is to develop and grow its venture and to optimize the management team s equity ownership stake. Significant growth
More informationCross-Border R&D in China Understanding the Regulatory Challenges
1 2 Cross-Border R&D in China Understanding the Regulatory Challenges 1 Panelists Moderator: Paul A. Stewart, Silicon Valley Office Managing Partner, Foley & Lardner LLP Speakers: David Rosen, Partner,
More informationTechnology Commercialization Primer: Understanding the Basics. Leza Besemann
Technology Commercialization Primer: Understanding the Basics Leza Besemann 10.02.2015 Agenda Technology commercialization a. Intellectual property b. From lab to market Patents Commercialization strategy
More informationSupervision of Outside Business Activities (OBAs) and Private Securities Transactions Wednesday, November 9 3:30 p.m. 4:30 p.m.
Supervision of Outside Business Activities (OBAs) and Private Securities Transactions Wednesday, November 9 3:30 p.m. 4:30 p.m. Outside business activities (OBAs) and private securities transactions (PSTs)
More informationECU Research Commercialisation
The Framework This framework describes the principles, elements and organisational characteristics that define the commercialisation function and its place and priority within ECU. Firstly, care has been
More informationParkinson s World A transformational project by The Cure Parkinson s Trust
Parkinson s World A transformational project by The Cure Parkinson s Trust Executive Summary During my time working in the Parkinson s field, I have come to realise there is a patent lack of communication
More informationLaunching an Ambassador Board. Presented by Jessica Elkan
Launching an Ambassador Board Presented by Jessica Elkan What is an Ambassador Board? An Ambassador Board can serve many purposes for varying organizations. For this presentation, I m defining an Ambassador
More informationPolicy 7.6 Intellectual Property Policy
Policy 7.6 Intellectual Property Policy Responsible Official: VP for Research Administration Administering Division/Department: Technology Transfer Effective Date: March 15, 2011 Last Revision: July 14,
More informationCurriculum Vita. Paul H. Keckley, Ph.D. Career Focus: Expert on health system transformation. Career History: Current:
Curriculum Vita Paul H. Keckley, Ph.D. Career Focus: Expert on health system transformation Career History: Current: Managing Editor, The Keckley Report (2006-present) The Keckley Report is a weekly blog
More information9/27/2013. Office of Technology Transfer Overview. Impacts from NC State Technology Transfer. NC State s Office of Technology Transfer
Office of Technology Transfer Overview Cluster Hire Faculty Orientation September 25, Kelly B. Sexton, Ph.D. Director North Carolina State University Impacts from NC State Technology Transfer 800 U.S.
More informationIntellectual Property
Tennessee Technological University Policy No. 732 Intellectual Property Effective Date: July 1January 1, 20198 Formatted: Highlight Formatted: Highlight Formatted: Highlight Policy No.: 732 Policy Name:
More informationTECHNOLOGY, MIND & SOCIETY
MEDIA KIT TECHNOLOGY, MIND & SOCIETY AN APA CONFERENCE OCTOBER 3-5, 2019 WASHINGTON, DC GRAND HYATT AN APA CONFERENCE TMS.APA.ORG In 2018, the American Psychological Association hosted the inaugural Technology,
More informationWPI Intellectual Property A day in the life of the tech transfer office. Todd Keiller Director, Intellectual Property and Innovation
WPI Intellectual Property A day in the life of the tech transfer office Todd Keiller Director, Intellectual Property and Innovation Who does research? Federal and state governments Defense, public health,
More informationDepartment of Veterans Affairs Technology Transfer Program. John J. Kaplan, PhD, JD Director, Technology Transfer Program
Department of Veterans Affairs Technology Transfer Program John J. Kaplan, PhD, JD Director, Technology Transfer Program Technology Transfer The commercialization of inventions and discoveries made by
More informationDigital Health. Jiban Khuntia, PhD. Assistant Professor Business School University of Colorado Denver
Digital Health Jiban Khuntia, PhD Assistant Professor Business School University of Colorado Denver Digital Digital usually refers to something using digits, particularly binary digits. Examples: Digital
More informationA POLICY in REGARDS to INTELLECTUAL PROPERTY. OCTOBER UNIVERSITY for MODERN SCIENCES and ARTS (MSA)
A POLICY in REGARDS to INTELLECTUAL PROPERTY OCTOBER UNIVERSITY for MODERN SCIENCES and ARTS (MSA) OBJECTIVE: The objective of October University for Modern Sciences and Arts (MSA) Intellectual Property
More informationI. The First-to-File Patent System
America Invents Act: The Switch to a First-to-F BY WENDELL RAY GUFFEY AND KIMBERLY SCHREIBER 1 Wendell Ray Guffey Kimberly Schreiber The America Invents Act ( act ) was signed into law on September 16,
More informationData Sciences Entrepreneurship class
Data Sciences Entrepreneurship class Feb 2013 @Columbia_Tech Columbia Technology Ventures Columbia Technology Ventures www.techventures.columbia.edu techventures@columbia.edu Agenda for Today 1. Context
More informationCalifornia State University, Northridge Policy Statement on Inventions and Patents
Approved by Research and Grants Committee April 20, 2001 Recommended for Adoption by Faculty Senate Executive Committee May 17, 2001 Revised to incorporate friendly amendments from Faculty Senate, September
More informationTrans-Pacific Partnership Lost Important IP Provisions
Portfolio Media. Inc. 111 West 19 th Street, 5th Floor New York, NY 10011 www.law360.com Phone: +1 646 783 7100 Fax: +1 646 783 7161 customerservice@law360.com Trans-Pacific Partnership Lost Important
More informationAn investment in a patent for your invention could be the best investment you will ever
San Francisco Reno Washington D.C. Beijing, China PATENT TRADEMARK FUNDING BROKER INVENTOR HELP Toll Free: 1-888-982-2927 San Francisco: 415-515-3005 Facsimile: (775) 402-1238 Website: www.bayareaip.com
More informationGOALS FOR PRESENTATION
Shubha Ghosh Professor of Law Associate Director, INSITE University of Wisconsin, Madison GOALS FOR PRESENTATION Background Major Issues Policy Concerns 2 My Background PhD in Economics from Michigan and
More informationPatent Masters Symposium A part of the IPWatchdog Institute
Patent Masters Symposium A part of the IPWatchdog Institute Program Agenda * Monday, March 25, 2019 8:30am to 9:00am Registration & Continental Breakfast 9:00am to 9:15am Gene Quinn: Welcome & Introductions
More informationUsing Academic Licensing Agreements to Promote Global Social Responsibility
Using Academic Licensing Agreements to Promote Global Social Responsibility Equitable Licensing of Medical Research Results Charité - Universitätsmedizin Berlin April 26, 2009 Dr. Ashley J. Stevens Executive
More informationOverview. How is technology transferred? What is technology transfer? What is Missouri S&T technology transfer?
What is technology transfer? Technology transfer is a key component in the economic development mission of Missouri University of Science and Technology. Technology transfer complements the research mission
More informationTechnology and Innovation in the NHS Scottish Health Innovations Ltd
Technology and Innovation in the NHS Scottish Health Innovations Ltd Introduction Scottish Health Innovations Ltd (SHIL) has, since 2002, worked in partnership with NHS Scotland to identify, protect, develop
More informationSoftware Licensing and Pricing
One Day Intensive Introductory Workshop on Software Licensing and Pricing Organized by IPFACE & Venture Center Learn Organized by For whom When Where Contact Cost Registration Software as intellectual
More informationIdentifying and Managing Joint Inventions
Page 1, is a licensing manager at the Wisconsin Alumni Research Foundation in Madison, Wisconsin. Introduction Joint inventorship is defined by patent law and occurs when the outcome of a collaborative
More informationUniversity IP and Technology Management. University IP and Technology Management
University IP and Technology Management Yumiko Hamano WIPO University Initiative Program Innovation Division WIPO WIPO Overview IP and Innovation University IP and Technology Management Institutional IP
More informationINTELLECTUAL PROPERTY OVERVIEW. Patrícia Lima
INTELLECTUAL PROPERTY OVERVIEW Patrícia Lima October 14 th, 2015 Intellectual Property INDUSTRIAL PROPERTY (INPI) COPYRIGHT (IGAC) It protects technical and aesthetical creations, and trade distinctive
More informationHFMA January CFO Forum
HFMA January CFO Forum January 26, 2018 St. Mark s Hospital Education Auditorium 1200 E. 3900 S. Salt Lake City, Utah 7.0 CPE hours 7:30 8:00 a.m. Continental Breakfast 8:00 8:15 a.m. Opening and Chapter
More informationBerlin Summit, Hotel Adlon Kempinski, April 26-27, 2012
Berlin Summit, Hotel Adlon Kempinski, April 26-27, 2012 Regulators + Payors + Providers + Pharma + Medtech + Investors presented by: roman rittweger advisors in healthcare Welcome to Innovations & Investments
More informationVistas International Internship Program
Vistas International Internship Program Find Yourself in a Place Where challenges aren t simply accepted, but sought. This is the new age of IP. This is Knobbe Martens. Who We Are Founded in 1962, Knobbe
More informationNorthwestern Intellectual Property Policies. OSR-Evanston Quarterly Network Monday, April 13 th Ben Frey, J.D., Senior Contracts Manager
Northwestern Intellectual Property Policies OSR-Evanston Quarterly Network Monday, April 13 th Ben Frey, J.D., Senior Contracts Manager Overview Define baseline terms (IP, patents, inventions, copyright)
More informationManaging Conflict of Interest
Managing Conflict of Interest The Challenge of Pharmaceutical Company Marketing to Medical Professionalism David J. Rothman, Ph.D. Bernard Schoenberg Professor of Social Medicine Columbia College of Physicians
More informationWIRED BIOSCIENCE INSTITUTE. February 5-6, 2008 Winston Salem, North Carolina
Day 1: February 5, 2008 WIRED BIOSCIENCE INSTITUTE February 5-6, 2008 Winston Salem, North Carolina 7:30-8:30am 8:30-9:00am 9:00-10:00am 10:00-10:15am 10:15-11:30am Registration Welcome, Opening Remarks,
More informationHow to Attract Venture Capital
How to Attract Venture Capital and Key Issues to Consider in Your Supply Relationships 6 th Annual Global Pharmaceutical Contract Manufacturing 25 th June 2013 Christian Wyss, VISCHER AG, Switzerland How
More informationTechnology Transfer & Inventing in Academia
Technology Transfer & Inventing in Academia Markey Pathway Students August 28, 2014 Nichole R. Mercier, Ph.D. Associate Director, Office of Technology Management http://otm.wustl.edu Office of Technology
More informationF98-3 Intellectual/Creative Property
F98-3 (A.S. 1041) Page 1 of 7 F98-3 Intellectual/Creative Property Legislative History: At its meeting of October 5, 1998, the Academic Senate approved the following policy recommendation presented by
More informationUIDP26 Conference Agenda. Monday, April 16, Tuesday, April 17, 2017
As of 1/30/2018 and subject to change All events at Cisco Systems, unless otherwise noted. Monday, April 16, 2018 11:30 AM 5:30 PM Workshop Check-In and Registration LUNCH ON YOUR OWN 1:30 PM 5:30 PM UIDP
More informationMORGAN STATE UNIVERSITY PROCEDURES ON PATENTS AND TECHNOLOGY TRANSFER APPROVED BY THE PRESIDENT NOVEMBER 2, 2015
MORGAN STATE UNIVERSITY PROCEDURES ON PATENTS AND TECHNOLOGY TRANSFER APPROVED BY THE PRESIDENT NOVEMBER 2, 2015 I. Introduction The Morgan State University (hereinafter MSU or University) follows the
More informationSMA Europe Code of Practice on Relationships with the Pharmaceutical Industry
Introduction SMA Europe Code of Practice on Relationships with the Pharmaceutical Industry SMA Europe is an umbrella body of national Spinal Muscular Atrophy patient representative and research organisations
More informationAccounting & Auditing Conference Illinois CPA Society. Stay Current on the New, Revised, and Ever Changing Standards that Affect You Most.
EARLY BIRD DISCOUNT Register by November 9, 2016 2016 Illinois CPA Society November 30, 2016 Rosemont, IL December 1, 2016 Springfield, IL Accounting & Auditing Conference Stay Current on the New, Revised,
More informationINSTITUTE OF MEDICINE COMMITTEE ON THE U.S. COMMITMENT TO GLOBAL HEALTH
INSTITUTE OF MEDICINE COMMITTEE ON THE U.S. COMMITMENT TO GLOBAL HEALTH Sharing Information, Knowledge and Materials Dr. Ashley J. Stevens Executive Director, Technology Transfer Senior Research Associate
More informationUniversity Senate agenda, June 5, 1986: PATENT AND TECHNOLOGY TRANSFER POLICY EXECUTIVE SUMMARY
University Senate agenda, June 5, 1986: PATENT AND TECHNOLOGY TRANSFER POLICY EXECUTIVE SUMMARY The impact of technical change on society is increasing and all aspects of this change are receiving increased
More informationCommittee on Development and Intellectual Property (CDIP)
E CDIP/10/13 ORIGINAL: ENGLISH DATE: OCTOBER 5, 2012 Committee on Development and Intellectual Property (CDIP) Tenth Session Geneva, November 12 to 16, 2012 DEVELOPING TOOLS FOR ACCESS TO PATENT INFORMATION
More informationDRAFT Agenda. designed to Policy at. This one. and wrong! Content: level. the main. their. This day. dealing with
Day 1: Setting up an IP focused technology transfer support at National, University of Faculty level: Establishing the necessary framework conditions. Understating and being able to clearly regulate the
More informationManaging Intellectual Property Assets: The NIH OTT Perspective
2009/SOM1/IPEG/SEM/003 Session: 2 Managing Intellectual Property Assets: The NIH OTT Perspective Submitted by: United States From Mind to Market: The Highs and Lows of Technology Transfer Singapore 23-24
More informationUniversity of Connecticut
University of Connecticut Office of Technology Commercialization (OTC) Commercialization - Technology Transfer at UConn Why Commercialize? Inventor: To see invention used To obtain research support and
More informationEQUITY STRUCTURES FOR HIGH GROWTH ENTREPRENEURIAL VENTURES
I. Introduction EQUITY STRUCTURES FOR HIGH GROWTH ENTREPRENEURIAL VENTURES Authored By Philip N. Krause Two categories of entrepreneurial ventures: Revenue Model Growth Model this is what we are discussing
More informationIntellectual Property Policy. DNDi POLICIES
Intellectual Property Policy DNDi POLICIES DNDi hereby adopts the following intellectual property (IP) policy: I. Preamble The mission of DNDi is to develop safe, effective and affordable new treatments
More informationPatenting Strategies. The First Steps. Patenting Strategies / Bernhard Nussbaumer, 12/17/2009 1
Patenting Strategies The First Steps Patenting Strategies / Bernhard Nussbaumer, 12/17/2009 1 Contents 1. The pro-patent era 2. Main drivers 3. The value of patents 4. Patent management 5. The strategic
More information[Definitions of terms that are underlined are found at the end of this document.]
Policy Direction - Pharmaceutical Industry Relationships [Definitions of terms that are underlined are found at the end of this document.] Rationale and Relationship to Mission, Principles and Values The
More informationCounterfeit, Falsified and Substandard Medicines
Meeting Summary Counterfeit, Falsified and Substandard Medicines Charles Clift Senior Research Consultant, Centre on Global Health Security December 2010 The views expressed in this document are the sole
More information